QR Kodea

Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol

Abstract Background Mixed dyslipidemia [elevated non-high-density lipoprotein cholesterol (non-HDL-C) and triglycerides (TGs), and decreased HDL-C] is common in type 2 diabetes mellitus (T2DM) and is associated with increased cardiovascular risk. Non-HDL-C and apolipoprotein B (ApoB) are the preferr...

Deskribapen osoa

Gorde:
Egile Nagusiak: Helen M. Colhoun, Lawrence A. Leiter, Dirk Müller-Wieland, Bertrand Cariou, Kausik K. Ray, Francisco J. Tinahones, Catherine Domenger, Alexia Letierce, Marc Israel, Rita Samuel, Stefano Del Prato
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMC 2020-02-01
Saila:Cardiovascular Diabetology
Gaiak:
Alirocumab
PCSK9
Diabetes mellitus
Non-HDL-C
HDL-C
Triglycerides
Sarrera elektronikoa:https://doi.org/10.1186/s12933-020-0991-1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak